Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
3.49
Nov 17 • 3:59 PM ET Dollar change-0.20 Percentage change(-5.42%)
Aftermarket Close
3.48
Aftermarket • 6:51 PM ET Dollar change-0.01 Percentage change(-0.29%)
Index
RUT
Market Cap
151.38M
Enterprise Value
147.52M
Income
-0.82M
Sales
46.27M
Book/sh
0.42
Cash/sh
0.17
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
73
IPO
Apr 05, 1994
P/E
-
Forward P/E
116.33
PEG
-
P/S
3.27
P/B
8.34
P/C
20.57
P/FCF
-
EV/EBITDA
670.52
EV/Sales
3.19
Quick Ratio
2.27
Current Ratio
2.97
Debt/Eq
0.18
LT Debt/Eq
0.13
Option/Short
Yes / Yes
EPS (ttm)
-0.02
EPS next Y
0.03
EPS next Q
-0.00
EPS this Y
87.50%
EPS next Y
500.00%
EPS next 5Y
-
EPS past 3/5Y
33.31% -14.59%
Sales past 3/5Y
13.81% 11.21%
EPS Y/Y TTM
78.07%
Sales Y/Y TTM
18.43%
EPS Q/Q
127.98%
Sales Q/Q
11.19%
Insider Own
6.76%
Insider Trans
2.44%
Inst Own
59.04%
Inst Trans
-1.33%
ROA
-2.95%
ROE
-4.59%
ROIC
-3.74%
Gross Margin
61.90%
Oper. Margin
-1.24%
Profit Margin
-1.78%
SMA20
6.61%
SMA50
10.25%
SMA200
-10.18%
Trades
Shs Outstand
46.38M
Shs Float
40.44M
52W High
6.61 -47.19%
52W Low
2.86 22.03%
Volatility
10.50% 6.83%
ATR (14)
0.23
RSI (14)
56.15
Beta
0.46
Rel Volume
0.75
Avg Volume
223.85K
Volume
168,787
Perf Week
10.44%
Perf Month
15.56%
Perf Quarter
5.12%
Perf Half Y
-11.87%
Perf YTD
-39.93%
Perf Year
-22.27%
Perf 3Y
53.07%
Perf 5Y
-0.29%
Perf 10Y
693.18%
Prev Close
3.69
Price
3.49
Change %
-5.42%
Consensus
Buy
Avg. Price Target
$6.12
Implied Upside
+75.4%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 14, 2025Downgrade
PPiper Sandler
Overweight → Neutral$4.50+28.9%
Jul 25, 2024Resumed
RILY logoRB. Riley Securities
Buy$4+14.6%
Sep 07, 2023Initiated
LLake Street
Buy$4+14.6%
Sep 07, 2023Initiated
RILY logoRB. Riley Securities
Buy$4.50+28.9%
Nov 10, 2022Upgrade
PPiper Sandler
Neutral → Overweight$3 → $3.50+0.3%
Nov 10, 2022Upgrade
CCanaccord Genuity
Hold → Buy$3 → $4+14.6%
Jan 26, 2021Downgrade
PPiper Sandler
Overweight → Neutral$9 → $4.50+28.9%
Jan 26, 2021Downgrade
CCanaccord Genuity
Buy → Hold$5+43.3%
Aug 10, 2020Initiated
HH.C. Wainwright
Buy$16+358.5%
Jul 16, 2020Initiated
CCanaccord Genuity
Buy$13+272.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schiller EricChief Technology OfficerNov 13 '26Buy3.638,54631,02213,546Nov 17 04:07 PM
KALBERMATTEN ADAM RChief Commercial OfficerSep 08 '26Buy3.1632,000101,120394,017Sep 09 04:32 PM
KALBERMATTEN ADAM RChief Commercial OfficerJul 28 '26Option Exercise0.0075,0000387,500Aug 06 04:11 PM
KALBERMATTEN ADAM ROfficerAug 03 '26Proposed Sale4.2625,483108,629Aug 03 05:18 PM
KALBERMATTEN ADAM RPresident-Chief Commercial OffJun 11 '26Buy3.9412,50049,275312,500Jun 15 04:34 PM
Schiller EricChief Technology OfficerMay 18 '26Buy3.915,00019,5625,000May 20 04:41 PM
Tharby Linda MChief Executive OfficerMay 15 '26Buy3.901,1914,645620,622May 20 04:02 PM
Tharby Linda MChief Executive OfficerMay 14 '26Option Exercise0.0013,9770626,757May 19 05:08 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Option Exercise0.005,3270310,458May 18 04:39 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Buy3.885,00019,400305,131May 18 04:35 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Option Exercise0.008,1930316,340May 18 04:33 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Buy3.865,50021,248308,147May 18 04:31 PM
Tharby Linda MOfficerMay 14 '26Proposed Sale3.957,32628,915May 14 05:01 PM
Pazdan ChristopherChief Operating OfficerMar 16 '26Option Exercise0.005,06405,064Mar 18 04:47 PM
Adams Thomas EdwardChief Financial OfficerMar 16 '26Option Exercise0.005,40405,404Mar 18 04:45 PM
Tharby Linda MChief Executive OfficerMar 16 '26Option Exercise0.0015,968015,968Mar 18 04:42 PM
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
President & CEOMr. Adam Kalbermatten
CFOMr. Thomas Adams
Chief Operating OfficerMr. Christopher Pazdan
Chief Technology OfficerMr. Eric Schiller